BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36221381)

  • 1. MicroRNA expression within neuronal-derived small extracellular vesicles in frontotemporal degeneration.
    Pounders J; Hill EJ; Hooper D; Zhang X; Biesiada J; Kuhnell D; Greenland HL; Esfandiari L; Timmerman E; Foster F; Wang C; Walsh KB; Shatz R; Woo D; Medvedovic M; Langevin S; Sawyer RP
    Medicine (Baltimore); 2022 Oct; 101(40):e30854. PubMed ID: 36221381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression in extracellular vesicles as a novel blood-based biomarker for Alzheimer's disease.
    Kumar A; Su Y; Sharma M; Singh S; Kim S; Peavey JJ; Suerken CK; Lockhart SN; Whitlow CT; Craft S; Hughes TM; Deep G
    Alzheimers Dement; 2023 Nov; 19(11):4952-4966. PubMed ID: 37071449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.
    Chiam K; Mayne GC; Wang T; Watson DI; Irvine TS; Bright T; Smith LT; Ball IA; Bowen JM; Keefe DM; Thompson SK; Hussey DJ
    World J Gastroenterol; 2020 May; 26(20):2570-2583. PubMed ID: 32523312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study.
    Schneider R; McKeever P; Kim T; Graff C; van Swieten JC; Karydas A; Boxer A; Rosen H; Miller BL; Laforce R; Galimberti D; Masellis M; Borroni B; Zhang Z; Zinman L; Rohrer JD; Tartaglia MC; Robertson J;
    J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):851-858. PubMed ID: 29434051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Cargo in Wharton's Jelly MSC Small Extracellular Vesicles: Key Functionality to In Vitro Prevention and Treatment of Premature White Matter Injury.
    Tscherrig V; Cottagnoud S; Haesler V; Renz P; Surbek D; Schoeberlein A; Joerger-Messerli MS
    Stem Cell Rev Rep; 2023 Oct; 19(7):2447-2464. PubMed ID: 37523115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
    Woollacott IOC; Nicholas JM; Heslegrave A; Heller C; Foiani MS; Dick KM; Russell LL; Paterson RW; Keshavan A; Fox NC; Warren JD; Schott JM; Zetterberg H; Rohrer JD
    Alzheimers Res Ther; 2018 Aug; 10(1):79. PubMed ID: 30111356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
    Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
    Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small RNA sequencing of circulating small extracellular vesicles microRNAs in patients with amyotrophic lateral sclerosis.
    Kim JA; Park C; Sung JJ; Seo DJ; Choi SJ; Hong YH
    Sci Rep; 2023 Apr; 13(1):5528. PubMed ID: 37016037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of miRNAs in Small Neuron-Derived Extracellular Vesicles of Alzheimer's Disease Patients and the Effect of Extracellular Vesicles on Microglial Immune Responses.
    Durur DY; Tastan B; Ugur Tufekci K; Olcum M; Uzuner H; Karakülah G; Yener G; Genc S
    J Mol Neurosci; 2022 Jun; 72(6):1182-1194. PubMed ID: 35488079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease.
    Serpente M; Fenoglio C; D'Anca M; Arcaro M; Sorrentino F; Visconte C; Arighi A; Fumagalli GG; Porretti L; Cattaneo A; Ciani M; Zanardini R; Benussi L; Ghidoni R; Scarpini E; Galimberti D
    Cells; 2020 Jun; 9(6):. PubMed ID: 32531989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer's disease.
    Derkow K; Rössling R; Schipke C; Krüger C; Bauer J; Fähling M; Stroux A; Schott E; Ruprecht K; Peters O; Lehnardt S
    PLoS One; 2018; 13(7):e0200602. PubMed ID: 30011310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma.
    Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F
    Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma proteome profiling identifies changes associated to AD but not to FTD.
    Mofrad RB; Del Campo M; Peeters CFW; Meeter LHH; Seelaar H; Koel-Simmelink M; Ramakers IHGB; Middelkoop HAM; De Deyn PP; Claassen JAHR; van Swieten JC; Bridel C; Hoozemans JJM; Scheltens P; van der Flier WM; Pijnenburg YAL; Teunissen CE
    Acta Neuropathol Commun; 2022 Oct; 10(1):148. PubMed ID: 36273219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementia.
    Heywood WE; Hallqvist J; Heslegrave AJ; Zetterberg H; Fenoglio C; Scarpini E; Rohrer JD; Galimberti D; Mills K
    Neurobiol Aging; 2018 Dec; 72():171-176. PubMed ID: 30292090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.
    Siedlecki-Wullich D; Català-Solsona J; Fábregas C; Hernández I; Clarimon J; Lleó A; Boada M; Saura CA; Rodríguez-Álvarez J; Miñano-Molina AJ
    Alzheimers Res Ther; 2019 May; 11(1):46. PubMed ID: 31092279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia.
    Piscopo P; Grasso M; Puopolo M; D'Acunto E; Talarico G; Crestini A; Gasparini M; Campopiano R; Gambardella S; Castellano AE; Bruno G; Denti MA; Confaloni A
    J Alzheimers Dis; 2018; 65(2):455-464. PubMed ID: 30056425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia.
    Fenoglio C; Serpente M; Visconte C; Arcaro M; Sorrentino F; D'Anca M; Arighi A; Rotondo E; Vimercati R; Rossi G; Scarpini E; Galimberti D
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlap between frontotemporal dementia and Alzheimer's disease: cerebrospinal fluid pattern and neuroimaging study.
    Padovani A; Premi E; Pilotto A; Gazzina S; Cosseddu M; Archetti S; Cancelli V; Paghera B; Borroni B
    J Alzheimers Dis; 2013; 36(1):49-55. PubMed ID: 23568100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.